Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

antibodies Press Releases

  + XML/RSS  



By MoBiTec GmbH
MoBiTec, Germany, partners with the Estonian biotechnology company Protobios to offer Mimotope Variation Analysis (MVA)-based antibody epitope mapping service to scientists worldwide.

By AbboMax, Inc.
Phosphorylation plays critical roles in the regulation of many cellular processes. It turns many protein enzymes on and off, thereby altering their function and activity. AbboMax, Inc. has developed over 140 phosphospecific antibodies.

By AbboMax, Inc.
Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer, used as vehicles for drug delivery. AbboMax offers innovative liposome reagents with a large number of lipid compositions.

By ImmunoReagents, Inc.
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced Abyntek Biopharma as its new distributor in Spain.

By ImmunoReagents, Inc.
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Ozyme as its new distributor in France.

By tebu-bio
tebu-bio announces today a distributor agreement with research antibody maker Biosensis bringing innovative tools for Life Sciences to European researchers

By Cambridge Healthtech Institute
CHI’s 4th Annual Cancer Biologics, February 13-15, 2013, San Francisco, CA

By www.gtcbio.com
GTC is proud to present the Immune Responses in Tumor Microenvironment Workshop on Jan 30, 2013 in San Diego, CA.

By www.gtcbio.com
Ronald Swanson, Senior Director, Janssen R&D Will Give a Featured Presentation at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 – Feb 1, 2013 in San Diego, CA)

By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US

By Cambridge Healthtech Institute
“CHI's Immunogenicity Assessment and Clinical Relevance,” takes place on Oct. 10-11, 2012 in Bethesda, MD.

By SMi Group
Consider novel linker strategy techniques to increase efficacy of ADC products

By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

By Particular GmbH
While the gold price keeps setting new records, nanoparticles from pure gold are also gaining importance in biotechnology. Particular GmbH from Germany now uses a laser method to produce them with high purity and conjugate them with high efficiency.

All Press Releases

By MoBiTec GmbH
MoBiTec, Germany, partners with the Estonian biotechnology company Protobios to offer Mimotope Variation Analysis (MVA)-based antibody epitope mapping service to scientists worldwide.

By SMi Group
DMPK Project Leader to present a keynote address at Immunogenicity 2014

By SMi Group
SMi is proud to announce that expert Ronit Mazor will be presenting about her study on “Identifying and removing T cell epitopes in immunotoxins” at the inaugural Immunogenicity Conference

By ImmunoReagents Inc
Major Increase in ELISA Signal Using Plasmonix QuantaWell™ Plates (Raleigh, NC) -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has established that...

By AbboMax, Inc.
Phosphorylation plays critical roles in the regulation of many cellular processes. It turns many protein enzymes on and off, thereby altering their function and activity. AbboMax, Inc. has developed over 140 phosphospecific antibodies.

By AbboMax, Inc.
Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer, used as vehicles for drug delivery. AbboMax offers innovative liposome reagents with a large number of lipid compositions.

By Cambridge Healthtech Institute
Complimentary case study download by Deborah Finco, Ph.D., Senior Principal Scientist, Drug Safety R&D, Pfizer, Inc.

By ImmunoReagents, Inc.
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced Abyntek Biopharma as its new distributor in Spain.

By ImmunoReagents, Inc.
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Ozyme as its new distributor in France.

By ImmunoReagents, Inc.
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of LabForce as its new distributor in Switzerland.

By tebu-bio
tebu-bio announces today a distributor agreement with research antibody maker Biosensis bringing innovative tools for Life Sciences to European researchers

By Cambridge Healthtech Institute
CHI’s 4th Annual Cancer Biologics, February 13-15, 2013, San Francisco, CA

By www.gtcbio.com
GTC is proud to present the Immune Responses in Tumor Microenvironment Workshop on Jan 30, 2013 in San Diego, CA.

By www.gtcbio.com
Ronald Swanson, Senior Director, Janssen R&D Will Give a Featured Presentation at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 – Feb 1, 2013 in San Diego, CA)

By ImmunoReagents, Inc
ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Labex Corporation as its new distributor in India.

By ImmunoReagents
ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Sungwoo Life Sciences as its new distributor in South Korea.

By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US

By Cambridge Healthtech Institute
“CHI's Immunogenicity Assessment and Clinical Relevance,” takes place on Oct. 10-11, 2012 in Bethesda, MD.

By ImmunoReagents Inc
(Raleigh, NC) -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of AmyJet Scientific as its new distributor in China.

By Brad Heidinger
ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Bioleague as its new distributor in Germany.

By SMi Group
Consider novel linker strategy techniques to increase efficacy of ADC products

By Brad Heidinger
ImmunoReagents, a manufacturer of high quality secondary antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Funakoshi as its new distributor for Japan.

By Report Buyer
New report: Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016

By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

By Vrisko Limited
Vrisko limited is now providing custom antibody services produced by the hybridoma technology. Our company has reached aggreement with leader biotechnology companies to provide the best monoclonal antibody services.

By UBIFRANCE
In Cell Art, a biotechnology company specialising in the development of innovative vaccines and antibodies, has announced today the launch of a US$33.1 million research-and-development project — the RN Armor Vax Consortium.

By Mathew Taylor
2B Scientific, a leading UK distributor of life science reagents now supplies antibodies, reagents and kits from IMGENEX Corporation.

By Particular GmbH
While the gold price keeps setting new records, nanoparticles from pure gold are also gaining importance in biotechnology. Particular GmbH from Germany now uses a laser method to produce them with high purity and conjugate them with high efficiency.

By Dr.Victor Marchione
Part two of the article series on your immune system focuses in on changes that can occur as we age. It's important to know what can happen, and what can further weaken your immune system. Let's get to it.

By Dr.Victor Marchione
And so begins my multi-part article on a very important subject: your immune system; the things inside you that attack foreign invaders and prevent disease from setting in. Before I get to the ways you can boost your own immunity,

By Randox Life Sciences
Randox Life Sciences has developed and manufactured a wide range of products including high quality, cost effective recombinant proteins, polyclonal antibodies and conjugates targeting drugs of abuse, steroids, hormones and biochemical markers.

By Cambridge Healthtech Institute
Featuring 12 conference programs within 4 streams focused on the current trends and science in antibody engineering and development (PEGSummit.com).

By Randox Laboratories
Randox Life Sciences is a recognised primary manufacturer of high quality, cost-effective human recombinant proteins, recombinant antibody fragments and polyclonal and monoclonal antibodies to classic and novel targets.

By SMi Group
Therapeutic antibodies are central to pharmaceutical development; needless to say, emphasis is continually on developing new methods and improving those already in place. Play an active role in the war against disease – register online today!

By Sara Pierre
tebu-bio is pleased to announce the renewal of their agreement with Advanced Biotechnologies for the distribution of their products throughout Europe.

By Mark Warne, CEO
UCB seeking to understand cell signalling mechanisms of therapeutic antibodies enabling identification of biomarkers

By AnaSpec, Eurogentec Group
Being the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research, AnaSpec is pleased to announce the release of the mouse monoclonal Anti-MOG (1-125).

By Kalorama Information
Although the therapeutic vaccine market has experienced a range of setbacks and disappointments, technological evolution should ultimately enable therapeutic vaccines to make similar commercial breakthroughs as monoclonal antibodies, notes Kalorama.

By AbboMax, inc.
AbboMax offers nine novel anti- histone H3 antibodies specific for a mono-, di-, or tri-methylated state of Lys4, Lys9, and Lys27 for the epigenetics research. .

By Bharatbook
Bharatbook added a new report on "Therapeutic Monoclonal Antibodies: World Market 2010-2025" which gives the potential applications and prospects on worldwide Therapeutic Monoclonal Antibodies.

By Kalorama Information
Oncology has emerged as the third largest segment in drug treatment, largely due to the growth of adjunctive therapies and high-cost of effective biotherapy. Sales have increased from $30 billion in 2005 to $65 billion forecasted for 2010.

By Kalorama Information
Because DNA vaccines generate cell-mediated immunity, the hope is that they will be effective against difficult viruses, even in cases where standard vaccines have failed to work.

By MarketsandMarkets
The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008.

By Bharatbook
Bharatbook added a new report on "Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025" explains how this market will develop, and where the opportunities will lie.

By Randox Laboratories
Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets.

By Bharatbook
MedImmune has agreed to license the rights to develop Trellis Bioscience's monoclonal antibody products for the treatment of respiratory syncytial virus (RSV).

By Izon Science
Izon Science unveil latest breakthrough in nanoparticle analysis at 2010 BIO International Convention in Chicago

By Fast Market Research
New Pharmaceuticals research report from Business Insights is now available from Fast Market Research

By Fast Market Research
Recently published research from Business Insights, "Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates", is now available at Fast Market Research

By Jhon carlos
Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, announce that they have launched the first TMEM97 antibody onto the market.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share